{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:11:33Z","timestamp":1789470693826,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research and Development Program of China","award":["2022YFC2705300"],"award-info":[{"award-number":["2022YFC2705300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-025-00903-6","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:00:36Z","timestamp":1739289636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Overlap prevalence and interaction effect of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Dongying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"3","key":"903_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"issue":"10","key":"903_CR2","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","volume":"7","author":"JM Paik","year":"2023","unstructured":"Paik JM, Henry L, Younossi Y, et al. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023;7(10):e0251.","journal-title":"Hepatol Commun"},{"key":"903_CR3","doi-asserted-by":"publisher","first-page":"111016","DOI":"10.1016\/j.diabres.2023.111016","volume":"206","author":"S Colosimo","year":"2023","unstructured":"Colosimo S, Mitra SK, Chaudhury T, et al. Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM. Diabetes Res Clin Pract. 2023;206:111016.","journal-title":"Diabetes Res Clin Pract"},{"issue":"26","key":"903_CR4","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","volume":"13","author":"K Qureshi","year":"2007","unstructured":"Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13(26):3540\u201353.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"903_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12072-023-10576-z","volume":"18","author":"CI Shih","year":"2024","unstructured":"Shih CI, Wu KT, Hsieh MH, et al. Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study. Hepatol Int. 2024;18(1):138\u201354.","journal-title":"Hepatol Int"},{"key":"903_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejim.2023.01.029","volume":"110","author":"ZQ Xie","year":"2023","unstructured":"Xie ZQ, Li HX, Wang BK, et al. Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: results from the NHANES study. Eur J Intern Med. 2023;110:62\u201370.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"903_CR7","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.jhep.2023.09.030","volume":"80","author":"T Yang","year":"2024","unstructured":"Yang T, Yin J, Li J, et al. The influence of different combinations of cardiometabolic risk factors on the prevalence of MASLD and risk of advanced fibrosis deserves attention. J Hepatol. 2024;80(2):e82\u20135.","journal-title":"J Hepatol"},{"issue":"5","key":"903_CR8","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835.","journal-title":"Hepatology"},{"issue":"6","key":"903_CR9","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","volume":"22","author":"M Kalligeros","year":"2024","unstructured":"Kalligeros M, Vassilopoulos A, Vassilopoulos S, et al. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020. Clin Gastroenterol Hepatol. 2024;22(6):1330-1332.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"903_CR10","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"key":"903_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12940-020-00585-y","volume":"19","author":"A Mendy","year":"2020","unstructured":"Mendy A, Wilkerson J, Salo PM, et al. Endotoxin clustering with allergens in house dust and asthma outcomes in a U.S. national study. Environ Health. 2020;19:35.","journal-title":"Environ Health"},{"issue":"1","key":"903_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cgh.2021.12.029","volume":"21","author":"E Vilar-Gomez","year":"2023","unstructured":"Vilar-Gomez E, Vuppalanchi R, Mladenovic A, et al. Prevalence of high-risk nonalcoholic steatohepatitis (NASH) in the United States: results from NHANES 2017\u20132018. Clin Gastroenterol Hepatol. 2023;21(1):115-124.e7. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.029.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"903_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dym157","volume":"36","author":"MJ Knol","year":"2007","unstructured":"Knol MJ, van der Tweel I, Grobbee DE, et al. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36(5):1111\u20138.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"903_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"9","key":"903_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"903_CR16","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/liv.15695","volume":"43","author":"S Ciardullo","year":"2023","unstructured":"Ciardullo S, Carbone M, Invernizzi P, et al. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. 2023;43(11):2425\u201333.","journal-title":"Liver Int"},{"issue":"1","key":"903_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"903_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2042-6410-3-13","volume":"3","author":"K Karastergiou","year":"2012","unstructured":"Karastergiou K, Smith SR, Greenberg AS, et al. Sex differences in human adipose tissues\u2014the biology of pear shape. Biol Sex Differ. 2012;3(1):13.","journal-title":"Biol Sex Differ"},{"issue":"12","key":"903_CR19","doi-asserted-by":"publisher","first-page":"e0324","DOI":"10.1097\/HC9.0000000000000324","volume":"7","author":"P Ochoa-Allemant","year":"2023","unstructured":"Ochoa-Allemant P, Marrero JA, Serper M. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. Hepatol Commun. 2023;7(12):e0324.","journal-title":"Hepatol Commun"},{"issue":"1","key":"903_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/oby.20426","volume":"22","author":"ALC Schneider","year":"2014","unstructured":"Schneider ALC, Lazo M, Selvin E, et al. Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity. 2014;22(1):292\u20139. https:\/\/doi.org\/10.1002\/oby.20426.","journal-title":"Obesity"},{"issue":"1","key":"903_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","volume":"49","author":"KL Ong","year":"2007","unstructured":"Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999\u20132004. Hypertension. 2007;49(1):69\u201375.","journal-title":"Hypertension"},{"issue":"8","key":"903_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/liv.13701","volume":"38","author":"NH Kim","year":"2018","unstructured":"Kim NH, Jung YS, Hong HP, et al. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease. Liver Int. 2018;38(8):1487\u201394.","journal-title":"Liver Int"},{"issue":"6","key":"903_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1053\/j.gastro.2007.03.055","volume":"132","author":"S Parekh","year":"2007","unstructured":"Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007;132(6):2191\u2013207.","journal-title":"Gastroenterology"},{"issue":"11","key":"903_CR24","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00535-013-0911-1","volume":"49","author":"T Nakahara","year":"2014","unstructured":"Nakahara T, Hyogo H, Yoneda M, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 2014;49(11):1477\u201384.","journal-title":"J Gastroenterol"},{"issue":"11","key":"903_CR25","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","volume":"7","author":"N Hossain","year":"2009","unstructured":"Hossain N, Afendy A, Stepanova M, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(11):1224\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11 Suppl 1","key":"903_CR26","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1210\/jc.2008-1399","volume":"93","author":"G Marchesini","year":"2008","unstructured":"Marchesini G, Moscatiello S, Di Domizio S, et al. Obesity-associated liver disease. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S74-80.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"903_CR27","doi-asserted-by":"publisher","first-page":"G697","DOI":"10.1152\/ajpgi.00426.2010","volume":"300","author":"DJ Chiang","year":"2011","unstructured":"Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G697-702.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"903_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121(1):91\u2013100.","journal-title":"Gastroenterology"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-00903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-025-00903-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-00903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:46:28Z","timestamp":1739461588000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-025-00903-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1186\/s12986-025-00903-6","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES databases are public available. The patients involved in the database is de-identified, and remained anonymous. Thus, institutional review board approval and consent to participates not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participates"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}